ASSOCIATION OF HYPOTHYROIDISM IN POLYCYSTIC OVARIAN SYNDROME
Main Article Content
Keywords
Abstract
ABSTRACT: AIM: Finding the prevalence of hypothyroidism in PCOS and to determine the association between hypothyroidism and various clinical and laboratory parameters in PCOS. SETTING: The study was conducted as a prospective observational study on 196 USG diagnosed cases of PCOS who attended the outpatient wing of MKCG Medical College Hospital, Berhampur, Odisha, India. METHODS: All the USG proven cases of PCOS were subjected to investigations like FSH, LH, FBS, PPBS, Serum Insulin, TSH, Free T3, Free T4. After an overnight fasting, basal venous blood sample was taken. TFT including TSH, Free T3 and Free T4 was estimated using chemiluminescence method. According to this, TSH normal range was taken as 0.34-4.25 µIU/ml, Free T3 normal range was 2.4-4.2 pg/ml, Free T4 normal range was 0.8-1.7 ng/dl137. TSH above 4.25 µIU/ml, Free T3 below 2.4 pg/ml and Free T4below 0.8 ng/dl was considered as overt hypothyroidism and high TSH with normal Free T3 and Free T4 are considered as subclinical hypothyroidism. RESULTS: The mean age of presentation was 27.28± 10.56 years. 78.57% of cases had menstrual complaints. 20.40 % 0f cases had Secondary Amenorrhoea, 56.12 % had Oligomenorrhoea, 2.04 % had Polymenorrhoea and 21.42% had normal menstrual cycles. 76.53 % of cases had Hyperandrogenism. 66.32 % had hirsuitism, out of which 69.23 % had mild hirsuitism, 29.23 % had moderate hirsuitism and 1.53 % had severe hirsuitism. 31.63% of cases had Acne.70 % of married cases had Infertility. Out of that 79.59 % had primary infertility and 20.40 % had secondary infertility. 38.77 % had infertility of duration 1-2 years, 51.02 % had infertility of 3-5 years and 10.20 % had infertility of >5 years. 64.28 % of cases had increased BMI (≥25 kg/m2). The prevalence of hypothyroidism in PCOS was 13.26 %. Out of that 57.69 % had subclinical hypothyroidism and 42.30 % had overt hypothyroidism. 96.15 % of PCOS with hypothyroidism had menstrual irregularities like oligomenorrhoea and secondary Amenorrhoea. This association was found to be statistically significant. 96.15 % of PCOS with hypothyroidism had features of hyperandrogenism like acne and hirsuitism. This association was found to be statistically significant.84.61 % of PCOS with hypothyroidism had increased BMI (≥25 kg/m2.) This association was found to be statistically significant. PCOS and Hypothyroidism are closely related. CONCLUSION: There is increased prevalence of hypothyroidism in PCOS. The relationship between thyroid profile and PCOS is being tried to be explored more and thus the problems of PCOS can be solved to some more extent.
Downloads
References
1. Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries, Am J ObstetGynecol 1935; 29: 181. 2. Frank.S. Polycystic ovary syndrome. N Engl J Med 1995; 333: 853-861. 3. Knochenhauer ES, Key, Azziz R et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the South-Eastern United States- A prospective study. J ClinEndocrinolMetab 1998; 83: 3078-3082. 4. Asuncion M, Calvo RM, Sancho J et al. A prospective study of the prevalence of polycystic ovary syndrome in unselected Caucasian women from Spain. J ClinEndocrinolMetab 2000; 85: 2434- 2438. 5. Ehrmann DA. Polycystic ovary syndrome. New Engl J Med 2005; 352: 1223-1236. 6. March WA, Moore VM, Willson KJ et al. The prevalence of PCOS in a community sample assessed under contrasting diagnostic criteria.HumReprod 2010; 25: 544-51. 7. Wijeyaratne CN, Balen AH, Barth JH, Belchetz PE. Clinical manifestations and insulin resistance in polycystic ovary syndrome among South Asians and Caucasians:is there a difference? ClinEndocrinol 2002; 57: 343—50. 8. Catherine M, DeUgarte, Alfred A. Bartolucci, Ricardo Azziz. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertility and Sterility 2005; 83(5): 1454-1460. 9. The Rotterdam ESHRE/ASRM—Revised 2003. Consensus on diagnostic criteria and long term health risks related to PCOS. Hum Reprod 2004; 19:41—7. 10. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. FertilSteril. 2004; 81:19–25. 11. Roberts CG, Ladenson PW. Hypothyroidism. Lancet. 2004; 363: 793–803. 12. Blackwell RE, Chang RJ. Report of the National Symposium on the Clinical Management of Prolactin-Related Reproductive Disorders. FertilSteril. 1986; 45: 607–10. 13. Krassas GE. Thyroid disease and female reproduction. FertilSteril. 2000; 74: 1063–70. 14. Janssen OE, Mehlmauer N, Hahn S et al. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol 2004; 150: 363-9. 15. Poppe K, Velkeniers B, Glinoer D. Thyroid disease and female reproduction. ClinEndocrinol 2007; 66:309-21. 16. Dahiya K, Sachdeva A, Singh V, Dahiya P, Singh R, Dhankhar R, Ghalaut P, Malik I.Reproductive hormone and Thyroid hormone profile in PCOS. Webmedcentral ENDOCRINOLOGY 2012; 3(6):WMC003455 17. DidemOzdemir, NeslihanCuhaci, Fevzi Balkan, AlperUsluogullari, ReyhanErsoy Prevalence of thyroid pathologies in patients with polycystic ovary syndrome. Endocrine Abstracts (2011) 26 P92&BekirCakir. 18. Z. Velija-Asimi, Sarajevo, Bosnia and Herzegovina. The role of subclinical hypothyroidism and vitamin D deficiency in the development of menstrual disorders in women with PCOS. Endocrine Abstracts (2012) 29P916. 19. Ralf Dittrich, Natia Kajaia, Susanne Cupisti, Inge Hoffmann, Matthias W Beckmann, Andreas Mueller. Association of thyroid-stimulating hormone with insulin resistance and androgen parameters in women with PCOS. Human Reproduction, vol.24, No 11, 2924-2930.
